Logo image of MYSZ

MY SIZE INC (MYSZ) Stock Fundamental Analysis

NASDAQ:MYSZ - Nasdaq - US62844N4060 - Common Stock - Currency: USD

1.48  +0.1 (+7.25%)

After market: 1.45 -0.03 (-2.03%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MYSZ. MYSZ was compared to 285 industry peers in the Software industry. MYSZ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, MYSZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MYSZ has reported negative net income.
In the past year MYSZ has reported a negative cash flow from operations.
MYSZ had negative earnings in each of the past 5 years.
In the past 5 years MYSZ always reported negative operating cash flow.
MYSZ Yearly Net Income VS EBIT VS OCF VS FCFMYSZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -39.72%, MYSZ is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
MYSZ has a worse Return On Equity (-57.82%) than 70.18% of its industry peers.
Industry RankSector Rank
ROA -39.72%
ROE -57.82%
ROIC N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
MYSZ Yearly ROA, ROE, ROICMYSZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

The Gross Margin of MYSZ (40.24%) is worse than 73.68% of its industry peers.
MYSZ's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MYSZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
MYSZ Yearly Profit, Operating, Gross MarginsMYSZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

4

2. Health

2.1 Basic Checks

MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MYSZ has been increased compared to 1 year ago.
MYSZ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MYSZ has an improved debt to assets ratio.
MYSZ Yearly Shares OutstandingMYSZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
MYSZ Yearly Total Debt VS Total AssetsMYSZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

MYSZ has an Altman-Z score of -7.86. This is a bad value and indicates that MYSZ is not financially healthy and even has some risk of bankruptcy.
MYSZ has a Altman-Z score of -7.86. This is amonst the worse of the industry: MYSZ underperforms 86.32% of its industry peers.
MYSZ has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MYSZ (0.04) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -7.86
ROIC/WACCN/A
WACC8.84%
MYSZ Yearly LT Debt VS Equity VS FCFMYSZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 3.03 indicates that MYSZ has no problem at all paying its short term obligations.
MYSZ's Current ratio of 3.03 is fine compared to the rest of the industry. MYSZ outperforms 73.33% of its industry peers.
MYSZ has a Quick Ratio of 2.09. This indicates that MYSZ is financially healthy and has no problem in meeting its short term obligations.
MYSZ has a better Quick ratio (2.09) than 62.11% of its industry peers.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 2.09
MYSZ Yearly Current Assets VS Current LiabilitesMYSZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

MYSZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.69%, which is quite impressive.
The Revenue has grown by 18.02% in the past year. This is quite good.
MYSZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 266.60% yearly.
EPS 1Y (TTM)79.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.74%
Revenue 1Y (TTM)18.02%
Revenue growth 3Y266.6%
Revenue growth 5YN/A
Sales Q2Q%-48.59%

3.2 Future

MYSZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.25% yearly.
MYSZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.77% yearly.
EPS Next Y82.6%
EPS Next 2Y37.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.8%
Revenue Next 2Y16.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MYSZ Yearly Revenue VS EstimatesMYSZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
MYSZ Yearly EPS VS EstimatesMYSZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 -100 -200 -300

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYSZ. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYSZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSZ Price Earnings VS Forward Price EarningsMYSZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSZ Per share dataMYSZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as MYSZ's earnings are expected to grow with 37.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.25%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYSZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MY SIZE INC

NASDAQ:MYSZ (4/17/2025, 8:00:00 PM)

After market: 1.45 -0.03 (-2.03%)

1.48

+0.1 (+7.25%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)N/A N/A
Inst Owners1.6%
Inst Owner Change0%
Ins Owners4.66%
Ins Owner Change-0.31%
Market Cap3.02M
Analysts82.86
Price Target3.06 (106.76%)
Short Float %1.19%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.54%
Min EPS beat(2)-61.76%
Max EPS beat(2)72.85%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.4%
Min Revenue beat(2)-42.94%
Max Revenue beat(2)-9.85%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.5
EV/EBITDA N/A
EPS(TTM)-23.68
EYN/A
EPS(NY)-2.75
Fwd EYN/A
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS4.05
BVpS3.39
TBVpS2.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.72%
ROE -57.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.24%
FCFM N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
F-Score6
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.23%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.03
Quick Ratio 2.09
Altman-Z -7.86
F-Score6
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)6.12%
Cap/Depr(5y)22.62%
Cap/Sales(3y)0.26%
Cap/Sales(5y)5.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.74%
EPS Next Y82.6%
EPS Next 2Y37.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.02%
Revenue growth 3Y266.6%
Revenue growth 5YN/A
Sales Q2Q%-48.59%
Revenue Next Year20.8%
Revenue Next 2Y16.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.36%
OCF growth 3YN/A
OCF growth 5YN/A